vidarabine phosphate and Breast Neoplasms

vidarabine phosphate has been researched along with Breast Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biagiotti, S; De Marco, C; Dominici, S; Magnani, M; Orlotti, N; Pierigè, F; Rossi, L; Serafini, S; Zaffaroni, N1
Bodey, GP; Kavanagh, JJ; Krakoff, IH1
Carpenter, JT; Raney, M; Vogel, CL; Wang, G1
Ahmed, T; Arlin, Z; Arnold, P; Ashikari, R; Mittelman, A; Savona, S1
Clark, GM; Diehl, V; Lathan, B; von Hoff, DD1

Trials

1 trial(s) available for vidarabine phosphate and Breast Neoplasms

ArticleYear
Phase II evaluation of fludarabine in patients with metastatic breast cancer: a Southeastern Cancer Study Group trial.
    Cancer treatment reports, 1986, Volume: 70, Issue:10

    Topics: Antimetabolites, Antineoplastic; Arabinonucleotides; Breast Neoplasms; Clinical Trials as Topic; Drug Evaluation; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Middle Aged; Neoplasm Metastasis; Vidarabine Phosphate

1986

Other Studies

4 other study(ies) available for vidarabine phosphate and Breast Neoplasms

ArticleYear
Cytotoxic activity of 2-Fluoro-ara-AMP and 2-Fluoro-ara-AMP-loaded erythrocytes against human breast carcinoma cell lines.
    International journal of oncology, 2010, Volume: 37, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Arabinonucleotides; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cytotoxins; DNA, Neoplasm; Drug Delivery Systems; Drug Evaluation, Preclinical; Erythrocytes; Female; Flow Cytometry; Humans; Time Factors; Vidarabine Phosphate

2010
Phase I study of fludarabine (2-fluoro-ara-AMP).
    European journal of cancer & clinical oncology, 1985, Volume: 21, Issue:9

    Topics: Adult; Aged; Agranulocytosis; Antimetabolites, Antineoplastic; Arabinonucleotides; Breast Neoplasms; Choriocarcinoma; Drug Evaluation; Female; Humans; Middle Aged; Pregnancy; Rhabdomyosarcoma; Sarcoma, Ewing; Thrombocytopenia; Uterine Cervical Neoplasms; Uterine Neoplasms; Vidarabine Phosphate

1985
Phase II trial of fludarabine phosphate (F-Ara-AMP) in patients with advanced breast cancer.
    Cancer chemotherapy and pharmacology, 1988, Volume: 22, Issue:1

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Arabinonucleotides; Breast Neoplasms; Drug Evaluation; Female; Humans; Middle Aged; Vidarabine Phosphate

1988
Cytotoxic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5-monophosphate (fludarabine, NSC 312887) in a human tumor cloning system.
    European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:12

    Topics: Antimetabolites, Antineoplastic; Arabinonucleotides; Breast Neoplasms; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Lymphoma, Non-Hodgkin; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vidarabine Phosphate

1988